IDH1 and central nervous system cancer: Although this provides an elegant explanation for the increased epileptogenicity of IDH1 mutant glioma, the D2HG concentrations needed for activation of NMDA receptors in vitro (10 mM) have been higher than the actual D2HG concentrations measured in the CNS of patients (1–6 mM)16,18.